China National Medicines Corporation Ltd. (600511.SS)
CNY 34.43
(1.89%)
CNY 34.43
(1.89%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.14 Billion CNY | 9.26% |
| 2022 | 1.96 Billion CNY | 11.97% |
| 2021 | 1.75 Billion CNY | 26.86% |
| 2020 | 1.38 Billion CNY | -13.79% |
| 2019 | 1.6 Billion CNY | 14.23% |
| 2018 | 1.4 Billion CNY | 23.01% |
| 2017 | 1.14 Billion CNY | 108.45% |
| 2016 | 547.6 Million CNY | 6.78% |
| 2015 | 512.84 Million CNY | 6.26% |
| 2014 | 482.65 Million CNY | 17.29% |
| 2013 | 411.5 Million CNY | 22.54% |
| 2012 | 335.81 Million CNY | 23.8% |
| 2011 | 271.26 Million CNY | -12.5% |
| 2010 | 310.01 Million CNY | 36.81% |
| 2009 | 226.59 Million CNY | 16.91% |
| 2008 | 193.82 Million CNY | 47.84% |
| 2007 | 131.1 Million CNY | 54.95% |
| 2006 | 84.61 Million CNY | 67.98% |
| 2005 | 50.37 Million CNY | 43.78% |
| 2004 | 35.03 Million CNY | 7.0% |
| 2003 | 32.73 Million CNY | 25.04% |
| 2002 | 26.18 Million CNY | 31.86% |
| 2001 | 19.85 Million CNY | 41.94% |
| 2000 | 13.98 Million CNY | 37.7% |
| 1999 | 10.15 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 541.05 Million CNY | 17.76% |
| 2024 Q1 | 459.45 Million CNY | -32.8% |
| 2024 Q3 | 480.76 Million CNY | -11.14% |
| 2023 Q2 | 570.15 Million CNY | 37.58% |
| 2023 Q1 | 414.4 Million CNY | -22.17% |
| 2023 FY | 2.14 Billion CNY | 9.26% |
| 2023 Q4 | 683.7 Million CNY | 43.12% |
| 2023 Q3 | 477.71 Million CNY | -16.21% |
| 2022 Q3 | 569.38 Million CNY | 16.58% |
| 2022 Q1 | 373.84 Million CNY | -17.38% |
| 2022 Q4 | 532.42 Million CNY | -6.49% |
| 2022 FY | 1.96 Billion CNY | 11.97% |
| 2022 Q2 | 488.4 Million CNY | 30.64% |
| 2021 Q3 | 535.75 Million CNY | 14.47% |
| 2021 FY | 1.75 Billion CNY | 26.86% |
| 2021 Q2 | 468.04 Million CNY | 57.16% |
| 2021 Q1 | 297.8 Million CNY | -21.2% |
| 2021 Q4 | 452.47 Million CNY | -15.54% |
| 2020 Q2 | 387.86 Million CNY | 67.2% |
| 2020 Q4 | 377.91 Million CNY | -1.83% |
| 2020 FY | 1.38 Billion CNY | -13.79% |
| 2020 Q1 | 231.97 Million CNY | -56.44% |
| 2020 Q3 | 384.93 Million CNY | -0.75% |
| 2019 Q2 | 468.16 Million CNY | 63.44% |
| 2019 Q1 | 286.44 Million CNY | -36.85% |
| 2019 Q4 | 532.58 Million CNY | 68.16% |
| 2019 FY | 1.6 Billion CNY | 14.23% |
| 2019 Q3 | 316.7 Million CNY | -32.35% |
| 2018 Q2 | 381.09 Million CNY | 49.55% |
| 2018 Q3 | 314.56 Million CNY | -17.46% |
| 2018 Q1 | 254.82 Million CNY | -16.65% |
| 2018 Q4 | 453.6 Million CNY | 44.2% |
| 2018 FY | 1.4 Billion CNY | 23.01% |
| 2017 Q4 | 305.72 Million CNY | 8.46% |
| 2017 Q1 | 141.41 Million CNY | 25.86% |
| 2017 Q2 | 412.47 Million CNY | 191.67% |
| 2017 Q3 | 281.87 Million CNY | -31.66% |
| 2017 FY | 1.14 Billion CNY | 108.45% |
| 2016 FY | 547.6 Million CNY | 6.78% |
| 2016 Q2 | 169.24 Million CNY | 37.84% |
| 2016 Q1 | 122.78 Million CNY | 1.04% |
| 2016 Q4 | 112.36 Million CNY | -21.54% |
| 2016 Q3 | 143.21 Million CNY | -15.38% |
| 2015 Q4 | 121.51 Million CNY | -7.12% |
| 2015 FY | 512.84 Million CNY | 6.26% |
| 2015 Q3 | 130.83 Million CNY | -13.58% |
| 2015 Q2 | 151.4 Million CNY | 38.79% |
| 2015 Q1 | 109.08 Million CNY | 1.19% |
| 2014 FY | 482.65 Million CNY | 17.29% |
| 2014 Q2 | 141.99 Million CNY | 39.18% |
| 2014 Q1 | 102.01 Million CNY | 13.01% |
| 2014 Q4 | 107.8 Million CNY | -17.6% |
| 2014 Q3 | 130.83 Million CNY | -7.86% |
| 2013 Q3 | 122.52 Million CNY | 5.54% |
| 2013 Q2 | 116.09 Million CNY | 40.53% |
| 2013 Q1 | 82.61 Million CNY | 32.34% |
| 2013 FY | 411.5 Million CNY | 22.54% |
| 2013 Q4 | 90.27 Million CNY | -26.32% |
| 2012 Q4 | 62.42 Million CNY | -40.39% |
| 2012 Q1 | 69.6 Million CNY | 125.17% |
| 2012 Q2 | 99.06 Million CNY | 42.33% |
| 2012 Q3 | 104.71 Million CNY | 5.7% |
| 2012 FY | 335.81 Million CNY | 23.8% |
| 2011 FY | 271.26 Million CNY | -12.5% |
| 2011 Q1 | 61.61 Million CNY | 40.17% |
| 2011 Q4 | 30.91 Million CNY | -63.65% |
| 2011 Q3 | 85.04 Million CNY | -9.22% |
| 2011 Q2 | 93.68 Million CNY | 52.04% |
| 2010 Q4 | 43.96 Million CNY | -63.97% |
| 2010 FY | 310.01 Million CNY | 36.81% |
| 2010 Q3 | 122.01 Million CNY | 64.5% |
| 2010 Q2 | 74.17 Million CNY | 6.17% |
| 2010 Q1 | 69.86 Million CNY | 83.63% |
| 2009 Q1 | 58.14 Million CNY | 40.24% |
| 2009 Q4 | 38.04 Million CNY | -39.13% |
| 2009 FY | 226.59 Million CNY | 16.91% |
| 2009 Q3 | 62.5 Million CNY | -7.96% |
| 2009 Q2 | 67.9 Million CNY | 16.8% |
| 2008 FY | 193.82 Million CNY | 47.84% |
| 2008 Q4 | 41.45 Million CNY | -8.07% |
| 2008 Q3 | 45.09 Million CNY | -24.4% |
| 2008 Q2 | 59.65 Million CNY | 25.29% |
| 2008 Q1 | 47.61 Million CNY | 98.71% |
| 2007 Q4 | 23.96 Million CNY | -28.52% |
| 2007 Q1 | 37.26 Million CNY | 121.79% |
| 2007 Q2 | 36.35 Million CNY | -2.44% |
| 2007 FY | 131.1 Million CNY | 54.95% |
| 2007 Q3 | 33.52 Million CNY | -7.78% |
| 2006 Q1 | 23.72 Million CNY | 214.56% |
| 2006 FY | 84.61 Million CNY | 67.98% |
| 2006 Q4 | 16.8 Million CNY | -23.8% |
| 2006 Q3 | 22.04 Million CNY | 0.04% |
| 2006 Q2 | 22.04 Million CNY | -7.09% |
| 2005 FY | 50.37 Million CNY | 43.78% |
| 2005 Q4 | 7.54 Million CNY | -37.8% |
| 2005 Q1 | 18.24 Million CNY | 317.67% |
| 2005 Q3 | 12.12 Million CNY | -2.74% |
| 2005 Q2 | 12.46 Million CNY | -31.66% |
| 2004 Q4 | 4.36 Million CNY | -50.65% |
| 2004 Q3 | 8.84 Million CNY | -4.63% |
| 2004 FY | 35.03 Million CNY | 7.0% |
| 2004 Q2 | 9.27 Million CNY | -25.98% |
| 2004 Q1 | 12.53 Million CNY | 342.36% |
| 2003 Q2 | 10 Million CNY | -6.17% |
| 2003 Q1 | 10.66 Million CNY | 7095.44% |
| 2003 FY | 32.73 Million CNY | 25.04% |
| 2003 Q4 | 2.83 Million CNY | -69.32% |
| 2003 Q3 | 9.23 Million CNY | -7.7% |
| 2002 Q4 | -152.44 Thousand CNY | -101.29% |
| 2002 Q3 | 11.86 Million CNY | 34.39% |
| 2002 FY | 26.18 Million CNY | 31.86% |
| 2002 Q2 | 8.82 Million CNY | 56.34% |
| 2002 Q1 | 5.64 Million CNY | 0.0% |
| 2001 FY | 19.85 Million CNY | 41.94% |
| 2000 FY | 13.98 Million CNY | 37.7% |
| 1999 FY | 10.15 Million CNY | 0.0% |